Opinion: Needy CT patients won’t benefit from 340B changes

CT Mirror – Monday, May 4, 2026
By Dawn Holcombe

Recently, the Human Services Committee of the Connecticut General Assembly reported a bill out of the committee with proposed changes to the 340B Drug Pricing Program. The legislation as amended, SB 494, includes a provision that would require biopharmaceutical manufacturers to ship 340B drugs to all contract pharmacies that contract with 340B “covered entities,” and by extension offer 340B pricing at these locations.

Dawn Holcombe is Executive Director of the Connecticut Oncology Association.

Click here to read the entire article.